Hard imes For Cancer Control – Six Contracts Ended; Rochester’s Community Proposal Rejected
In Brief: In Vitro Systems Will Be 90% Reliable, Ames Says; GAO Asks For Reassessment of Saccharin
DeVita’s “Radical” Statement – Resectability Rate Should Be The Cure Rate
Rauscher Disappointed In CREG Progress
Cancer Commission Surveying for Pill, Hepatoma Association
President Accepts Rauscher Resignation
NCI Urged To Back Ultrasounds Studies
Schmidt Attempted To Answer Critics
Trending Stories
- DOD cancer research programs face 57% funding cut in year-long continuing resolution
Pancreatic, lung, kidney cancer research programs eliminated - Karen Knudsen tells us why she took the CEO job at the Parker Institute for Cancer Immunotherapy
- Brian Druker, developer of Gleevec, eyes a new feat: Setting the Boston Marathon fundraising record
Current record: $507,000. Proceeds to go to LLS as NIH funding is slashed - What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns” - Amid HHS upheaval, Bhattacharya takes the helm at NIH, Makary at FDA
Meanwhile, NASEM sounds “SOS” for health infrastructure - Alec Kimmelman announced as next CEO and Dean of NYU Langone Health